Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does AXICABTAGENE CILOLEUCEL Cause Encephalopathy? 292 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 292 reports of Encephalopathy have been filed in association with AXICABTAGENE CILOLEUCEL (YESCARTA). This represents 3.4% of all adverse event reports for AXICABTAGENE CILOLEUCEL.

292
Reports of Encephalopathy with AXICABTAGENE CILOLEUCEL
3.4%
of all AXICABTAGENE CILOLEUCEL reports
58
Deaths
172
Hospitalizations

How Dangerous Is Encephalopathy From AXICABTAGENE CILOLEUCEL?

Of the 292 reports, 58 (19.9%) resulted in death, 172 (58.9%) required hospitalization, and 55 (18.8%) were considered life-threatening.

Is Encephalopathy Listed in the Official Label?

Yes, Encephalopathy is listed as a known adverse reaction in the official FDA drug label for AXICABTAGENE CILOLEUCEL.

What Other Side Effects Does AXICABTAGENE CILOLEUCEL Cause?

Cytokine release syndrome (4,140) Immune effector cell-associated neurotoxicity syndrome (1,821) Neurotoxicity (1,327) Pyrexia (859) Death (756) Disease progression (745) Hypotension (398) Neutropenia (391) Confusional state (299) Diffuse large b-cell lymphoma (291)

What Other Drugs Cause Encephalopathy?

BACLOFEN (845) METHOTREXATE (775) ACETAMINOPHEN (608) IFOSFAMIDE (585) CYCLOPHOSPHAMIDE (552) TACROLIMUS (523) PREDNISONE (489) DEXAMETHASONE (428) METFORMIN (418) ETOPOSIDE (404)

Which AXICABTAGENE CILOLEUCEL Alternatives Have Lower Encephalopathy Risk?

AXICABTAGENE CILOLEUCEL vs AXITINIB AXICABTAGENE CILOLEUCEL vs AZACITIDINE AXICABTAGENE CILOLEUCEL vs AZATHIOPRINE AXICABTAGENE CILOLEUCEL vs AZD-1222 AXICABTAGENE CILOLEUCEL vs AZELAIC ACID

Related Pages

AXICABTAGENE CILOLEUCEL Full Profile All Encephalopathy Reports All Drugs Causing Encephalopathy AXICABTAGENE CILOLEUCEL Demographics